OPA Bulletin

  • OPA Bulletin - June 18, 2019

    • New changes to the Universal Influenza Immunization Program (UIIP) for the upcoming 2019/2020 season
    • Updated evacuation notice for Pikangikum First Nation

    • Drugs in Chronic Kidney Disease: Implications for Pharmacists
    • Musculoskeletal and Nervous System Conditions
    • Implementing Smoking Cessation Services in the Pharmacy

    • Check out PxP2019 Conference photos!
    • Correction Notice: Ask PSN Question from May 28, 2019

    • Business Expense Disability Insurance

    • Drug Shortage Notification for certain Products Presented in LifeShield™ and ANSYR™ Syringes
    • Drug Supply Health System Alert: Leucovorin Calcium Injection, 10 mg/mL, DIN 02087316
    • Drug Supply Health System Alert: Potassium Chloride for Injection Concentrate USP (2mEq/mL) in the 20mL format

    • Health Canada warns Canadians of potential cancer risk associated with gentian violet
    • Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21

  • OPA Bulletin - June 11, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: PxP2019 update on scope expansion
    • Pharmacy practice research winners at PxP2019
    • Opioid overdose: age is no safety net
    • Updated antiemetic recommendations
    • A limited quantity of U.S.-labeled potassium chloride for injection USP concentrate (2mEq/mL) in the 20mL format will be made available for Canadian patients
    • Fludarabine supply status and conservation strategies

    • Medical Devices Training For Pharmacy Technicians
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Ask the Practice Support Network

    • Do I really need life insurance?

    • DDD Notice No. 19086 posted June 05, 2019 Prescription Forgery Alert
    • DDD Notice No. 19087 posted June 06, 2019 Prescription Forgery Alert
    • DDD Notice No. 19090 posted June 10, 2019 Health Network System (HNS) and Narcotic Monitoring System (NMS) outages notification to ODP agencies

    • Health products manufactured by Konsar Future Nutrition Inc. may pose serious health risks

  • OPA Bulletin - June 4, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA announces award winners at PxP2019
    • Here's what you're missing at PxP2019!
    • Pikangikum evacuation plan

    • Women’s Health Conditions
    • Managing Your Pharmacy: The Business Essentials
    • Pharmacist Health Coaching - Cardiovascular Program Training Course

    • Ask the Customer Experience and Administration Team

    • Your questions answered on disability insurance

    • DDD Notice No. 19082 posted May 31, 2019 Prescription Forgery Alert
    • DDD Notice No. 19083 posted May 31, 2019 Identified Forgery Alert – 120 Oxycocet Pills
    • DDD Notice No. 19084 posted May 31, 2019 ODB gFOBT PIN to be Discontinued
    • DDD Notice No. 19085 posted June 04, 2019 Notice from the Executive Officer: Change to the Health Network System Subscription Agreement for Pharmacy Operators

    • Health Product InfoWatch - Safety Updates: Eliquis, Fentora and Keytruda
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Health Product Risk Communication - Update – Thursday, May 30th, 2019
    • IMPORTANT: Drug Shortage Notification – Multiple Sterile Injectable Products
    • Biocell breast implants - Information Update

  • OPA Bulletin - May 21, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Applications for the Universal Influenza Immunization Program (UIIP) are being accepted by the Ministry for 2019/20 influenza season
    • Be heard! Last chance to submit comments to Ministry on proposed amendments
    • Don't miss these PxP2019 conference sessions on scope of practice, drug shortages and cannabis
    • Sports journalist and mental health advocate, Michael Landsberg to open PxP2019 trade show

    • Injections and Immunizations Certificate Program - Blended
    • Injections and Immunizations Refresher - Blended
    • Delivering a Comprehensive Pharmacy-Based Vaccines Program

    • Check out our new membership benefit with Manulife Bank!*
    • Ask the Customer Experience and Administration Team

    • Time to renew your store insurance

    • DDD Notice No. 19078 posted May 17, 2019 Prescription Forgery Alert
    • DDD Notice No. 19080 posted May 21, 2019 Prescription Forgery Alert

    • Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity - Hoffmann-La Roche Limited

  • OPA Bulletin - May 14, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Deadline to provide feedback to government on amendments to regulations is May 24, 2019
    • OPA and Neighbourhood Pharmacies request your input to long-term care survey
    • OPA participates in conversation in long-term care at AdvantAge Convention
    • Spring 2019 Issue of Ontario Pharmacist featuring Q&A with conference keynote, André Picard, now available
    • Registered yet for conference? Deadline is approaching!

    • Medical Devices Training for Pharmacy Technicians
    • Personal Branding for Pharmacy Professionals
    • Dermatologic Conditions

    • Sneak preview to new membership benefit with Manulife Bank!
    • Ask the Practice Support Network

    • “Must Have Insurance”

    • DDD Notice No. 19075 posted May 10, 2019 Prescription Forgery Alert
    • DDD Notice No. 19072 posted May 09, 2019 Prescription Forgery Alert

  • OPA Bulletin - May 7, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Provide Your Feedback to Health Quality Ontario - A Quality Standard for Transitions from Hospital to Home
    • Drug Shortage Notification – Potassium Chloride for Injection Concentrate USP (2 mEq (mmol) / mL) and Epinephrine Injection USP 0.1 mg / mL (LifeShield Syringes)

    • Asthma Management: The Essentials
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Delivering a Comprehensive Pharmacy-Based Vaccines Program

    • Special Conference Promotion - Save $100
    • Last Week for Hotel Reservations for PxP2019
    • Ask the Customer Experience and Administration Team

    • Is your store properly insured?

    • DDD Notice No. 19070 posted May 02, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGE NOTIFICATION TO ODP AGENCIES
    • DDD Notice No. 19071 posted May 02, 2019 Prescription Forgery Alert

    • Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality

  • OPA Bulletin - April 30, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Your questions answered on recent proposed pharmacy regulations from Ontario government
    • Canadian Foundation for Pharmacy happenings
    • Pharmacies surpass doctors’ offices as primary venue for influenza vaccination
    • OPA represents at Momentum Loblaw/SDM trade show

    • An Update on Direct Oral Anticoagulation
    • Essential Cannabis Knowledge for Pharmacists - Certificate Program
    • Patient Assessment and Triage

    • First 100 will save $100 on conference registration
    • Ask the Practice Support Network
    • Spring time discounts with Royal Ontario Museum
    • Reminder to members in voting districts

    • Life Insurance v.s. Mortgage Insurance

    • DDD Notice No. 19066 posted April 25, 2019 Notice: Proposals to Establish More Efficient Pharmacy Reimbursement Policies
    • DDD Notice No. 19067 posted April 26, 2019 Notice from the Executive Officer
    • DDD Notice No. 19068 posted April 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19069 posted April 30, 2019 Prescription Forgery Alert

    • Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
    • Health Product InfoWatch
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion

  • OPA Bulletin - April 23, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Announcement to expand scope of practice for pharmacists generates public discussion
    • Apply to the Allied Health Professional Development Fund for Compensation of Conference Fees
    • OPA Celebrates National Immunization Awareness Week with Record Breaking Year for Flu Shots
    • Attention Pharmacies in Timmins, Cornwall, Kapuskasing and Thunder Bay - Potential Increase in NIHB Claims

    • An Update On Oral Anticoagulation
    • Managing Your Pharmacy: The Business Essentials
    • Assessing and Prescribing for Minor Ailments - Full Program

    • Meet the Future Leaders in Research at PxP2019
    • Ask the Customer Experience and Administration Team

    • Ask Us Your Questions on Critical Illness

    • ODB Formulary – Edition No. 43, Summary of Changes – April 2019 Summary of Product Changes

    • Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity
    • Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation

  • OPA Bulletin - April 16, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Provincial Budget Announces Expansion of Scope of Practice for Pharmacists
    • Conference Early Bird Deadline is Thursday
    • Express Scripts Canada - Pharmacy Provider Manual

    • Take-home Naloxone in Community Pharmacies
    • Methadone and Buprenorphine/ Naloxone Toolkit
    • Opioid Addictions and Substitution Therapy Online Modules

    • PxP2019 Conference Social Events
    • Ask the Practice Support Network

    • Are You Prepared for a Critical Illness?

    • DDD Notice No. 19062 posted April 12, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Zinecard (Dexrazoxane)
    • Health Canada approves updates to Mifegymiso prescribing information

  • OPA Bulletin - April 09, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OHIP+ Update
    • Conference Early Bird Deadline is April 18
    • Patient Tip Sheet - Managing a Diet While Taking Warfarin
    • April is IBS Awareness Month - Read our Blog Post for Pharmacists
    • Ontario College of Pharmacists Annual Report

    • NEW! Medical Devices Training for Pharmacy Technicians
    • Collaboration with Family Physicians: the Rx for Success
    • FAQs and a New Drug Update on Contraception and Abortion Care
    • Potential Funding Available for OPA Professional Development

    • Time-Limited WebCrasher Savings with OPA Partner, Dell
    • PxP2019 Speaker Spotlight: Women's Health, Polypharmacy and T2D
    • OPA Supports Partner in Naloxone Awareness Day at Queen's Park
    • Ask the Customer Experience and Administration Team

    • OPA Advantage Plus
    • Last Chance for Movie Tickets from COSECO

    • Drug Shortage / Supply Health System Alert: Dexrazoxane, Erwinia Asparaginase and Etoposide

    • Biocell breast implants - Information Update
    • BENLYSTA (belimumab) - Safety Alert

Back to top